Rapid Multislice T1 Mapping of Contrast-Enhanced Mouse Tumor Using Saturation Recovery Look-Locker Method with Spiral Readout
Yuchi Liu1, Zheng Han1, Kai Jiang2, Yun Jiang1, Yajuan Li1, Zheng-Rong Lu1, and Xin Yu1,3,4,5

1Biomedical Engineering, Case Western Reserve University, Cleveland, OH, United States, 2Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, United States, 3Radiology, Case Western Reserve University, Cleveland, OH, United States, 4Physiology and Biophysics, Case Western Reserve University, Cleveland, OH, United States, 5Case Center for Imaging Research, Case Western Reserve University, Cleveland, OH, United States

Synopsis

In this study, a rapid multislice saturation-recovery Look-Locker (MSRLL) T1 mapping method with spiral readout was developed for the application on tissues with long T1 value, such as tumor. This method was validated in vitro and evaluated in a dynamic contrast-enhanced MRI (DCE-MRI) study on mouse tumor. The spiral MSRLL method showed a strong agreement with Cartesian method, and achieved temporal resolution of 2 min 40s with a voxel size of 0.23×0.23×1 mm3 in vivo.

Target Audience

Researchers interested in fast T1 mapping, contrast-enhanced MRI and non-Cartesian imaging.

Introduction

Dynamic contrast-enhanced MRI (DCE-MRI) plays an important role in tumor imaging. The concentration of contrast agent can be quantified directly by measuring T1 changes. However, conventional inversion recovery T1 mapping method cannot track the dynamics of T1 changes due to its long acquisition time. Previously, a mulitslice saturation recovery Look-Locker (MSRLL) method with Cartesian encoding was developed and validated in our laboratory for fast cardiac T1 mapping in mice1. In this study, the MSRLL method was modified with spiral encoding to further accelerate T1 mapping for the application on tissues with long T1 value, such as tumor.

Methods

A multislice saturation-recovery Look-Locker T1 mapping method with spiral readout was modified based on the previous Cartesian MSRLL sequence1. A spiral trajectory of 32 interleaves with zero moment compensated was designed using the minimum-time gradient method2. The spiral trajectory was measured manually using an established method3 and the measured trajectory was used to reconstruct images using NUFFT4. Multi-slice images were acquired using the interlaced scheme to minimized cross-talk between slices. Saturation module was implemented at the beginning of each spiral interleave acquisition in k-space. T1 maps were obtained by pixel-wise curve fitting using an in-house developed MATLAB-based software as described previously1.

All MRI experiments were performed on a horizontal 7T Bruker scanner (Bruker Biospin Co., Billerica, MA). The spiral MSRLL method was validated in vitro on a multi-compartment phantom with manganese chloride (MnCl2) solutions. The concentrations of MnCl2 solutions were 0.03 mM, 0.1 mM, 0.3 mM, and 1 mM, respectively. Three slices were acquired using the spiral MSRLL method with 0.2 mm interslice gap. The following imaging parameters were used: flip angle 10°; echo time 2.09 ms; slice thickness 1 mm; number of average 1; field of view 3×3 cm2; matrix size 128×128. For each slice, 50 images that covered 5 s of the saturation recovery curve were acquired with an interval of 100 ms. Proton density (M0) images were acquired with repetition time (TR) of 2s. Cartesian MSRLL images were also acquired as a validation of spiral MSRLL method. Center 64 k-space lines were acquired in Cartesian method as described previously1. Other acquisition parameters were the same as spiral MSRLL.

The spiral MSRLL method was then evaluated in a DCE-MRI study on mouse tumor. A 4-week old athymic nude mouse was inoculated with 1×106 PC3 (ATCC® CRL1435) in flank. Imaging experiments were performed when tumor size reached 5-8 mm in diameter. An extradomain-B fibronectin (EDB-FN) targeted contrast agent, ZD2-Gd(HP-DO3A) was injected intravenously at the dose of 0.1 mmol/kg after acquiring pre-contrast images. This contrast agent preferably accumulates in tumor via targeting overexpressed EDB-FN in tumor extracellular matrix through a 7 amino-acid peptide, ZD25. Post-contrast T1 maps at 7 time points were acquired every 10 min to monitor contrast enhancement of tumor. 5 slices were acquired and other acquisition parameters were the same as the phantom study.

Results

Fig. 1 shows T1 maps of all three slices measured by spiral MSRLL method. There is no substantial difference in T1 values among the slices. Total acquisition time of Look-Locker and M0 images using spiral MSRLL and Cartesian MSRLL were 3min 44s and 7min 28s, respectively. The comparison of Cartesian and spiral T1 maps of the first slice was shown in Fig. 2a. T1 values measured using spiral MSRLL shows a strong agreement with Cartesian method (Fig. 2b). Fig. 3 shows in vivo T1 maps of one slice before and after contrast agent injection. The first map (Fig. 3a) was acquired before injection and the others (Fig. 3b-h) were acquired every 10 min after injection. Dynamic R1 change is shown in Fig. 4. R1 increased from 0.38 s-1 to 0.54 s-1 at 20-30 min post-injection, and decreased to 0.37 s-1 at 70 min post-injection.

Discussion & Conclusion

The spiral MSRLL method showed a strong agreement with Cartesian method, and achieved temporal resolution of 2 min 40s with a voxel size of 0.23×0.23×1 mm3 in vivo. This fast T1 mapping method is potentially applicable to cardiac imaging as well when combined with ECG trigger. Further acceleration can be achieved by combining with other fast imaging methods, such as compressed sensing.

Acknowledgements

This work was supported by National Heart, Lung, and Blood Institute Grants R01 HL73315.

References

1. Jiang et al. MRM. 2014.

2. Lee et al. MRM. 2003.

3. Duyn et al. JMRI. 1998.

4. Fessler and Sutton. IEEE Trans. Signal Process. 2003.

5. Han et al. Bioconjugate Chem. 2015.

Figures

Figure 1. T1 maps of all three slices acquired using spiral MSRLL.

Figure 2. Comparison of Cartesian and spiral T1 maps (a) and T1 values (b) of the first slice on phantoms 1-4.

Figure 3. T1 maps acquired before (a) and every 10 min after injection (b-h).

Figure 4. Time-course of R1 before and after injection in mouse tumor.



Proc. Intl. Soc. Mag. Reson. Med. 24 (2016)
2818